The European Commission approved on Friday the proposed merger of US drug manufacturers Pfizer and Wyeth, subject to Pfizer renouncing some of its animal health products in Europe.
Pfizer, already the world’s biggest pharmaceutical firm, announced the planned merger in January, seeking diversification as it prepares for the expiration of patents on its blockbuster drugs.
The US$68 billion deal appears to be the biggest takeover in the global pharmaceutical sector since Pfizer acquired Warner-Lambert Co for US$93.4 billion in 2000, financial analysts say.
COMMITMENT
The EU’s executive branch, which enforces EU competition law, said the merger was conditional on “Pfizer’s commitment to divest several types of animal health vaccines, pharmaceuticals and medicinal feed additives” in Europe.
“The commission had concerns that the transaction, as originally notified, would have raised competition issues in the field of animal health products on a number of national markets,” it said in a statement.
“In the light of the commitments offered by Pfizer, the Commission has now concluded that the proposed transaction would not significantly impede effective competition in the EEA or any substantial part of it.”
The European Economic Area (EEA) includes the 27 EU member states plus Iceland, Liechtenstein and Norway.
DIVESTMENT
In addition, the European Commission said Pfizer — best known for the anti-cholesterol treatment Lipitor and erectile dysfunction drug Viagra, as well as AIDS drugs — has offered to “divest” a Wyeth plant in Sligo, Ireland.
“In the area of human health, the companies’ activities are to a large extent complementary,” it said.
The merger still awaits a green light from competition authorities in the US, China and other jurisdictions, as well as approval from Wyeth shareholders, a statement on Pfizer’s Web site said.
If the deal goes ahead, the combined company will be No. 1 in terms of biopharmaceutical revenues in the US with a market share of about 12 percent. It will hold about 10 percent of the market in Europe.
Quanta Computer Inc (廣達) chairman Barry Lam (林百里) is expected to share his views about the artificial intelligence (AI) industry’s prospects during his speech at the company’s 37th anniversary ceremony, as AI servers have become a new growth engine for the equipment manufacturing service provider. Lam’s speech is much anticipated, as Quanta has risen as one of the world’s major AI server suppliers. The company reported a 30 percent year-on-year growth in consolidated revenue to NT$1.41 trillion (US$43.35 billion) last year, thanks to fast-growing demand for servers, especially those with AI capabilities. The company told investors in November last year that
Intel Corp has named Tasha Chuang (莊蓓瑜) to lead Intel Taiwan in a bid to reinforce relations between the company and its Taiwanese partners. The appointment of Chuang as general manager for Intel Taiwan takes effect on Thursday, the firm said in a statement yesterday. Chuang is to lead her team in Taiwan to pursue product development and sales growth in an effort to reinforce the company’s ties with its partners and clients, Intel said. Chuang was previously in charge of managing Intel’s ties with leading Taiwanese PC brand Asustek Computer Inc (華碩), which included helping Asustek strengthen its global businesses, the company
Taiwanese suppliers to Taiwan Semiconductor Manufacturing Co. (TSMC, 台積電) are expected to follow the contract chipmaker’s step to invest in the US, but their relocation may be seven to eight years away, Minister of Economic Affairs J.W. Kuo (郭智輝) said yesterday. When asked by opposition Chinese Nationalist Party (KMT) Legislator Niu Hsu-ting (牛煦庭) in the legislature about growing concerns that TSMC’s huge investments in the US will prompt its suppliers to follow suit, Kuo said based on the chipmaker’s current limited production volume, it is unlikely to lead its supply chain to go there for now. “Unless TSMC completes its planned six
TikTok abounds with viral videos accusing prestigious brands of secretly manufacturing luxury goods in China so they can be sold at cut prices. However, while these “revelations” are spurious, behind them lurks a well-oiled machine for selling counterfeit goods that is making the most of the confusion surrounding trade tariffs. Chinese content creators who portray themselves as workers or subcontractors in the luxury goods business claim that Beijing has lifted confidentiality clauses on local subcontractors as a way to respond to the huge hike in customs duties imposed on China by US President Donald Trump. They say this Chinese decision, of which Agence
RSS